Literature DB >> 12535803

The SCID-hu Skin mouse as a model to investigate selective chemokine mediated homing of human T-lymphocytes to the skin in vivo.

José M Carballido1, Tilo Biedermann, Christoph Schwärzler, Jan E de Vries.   

Abstract

Here we report the establishment of an in vivo mouse model that allows monitoring of human T cell migration into human skin. This model is based on the use of severe combined immunodeficiency (SCID) mice transplanted with human skin (SCID-hu Skin mice). Adoptively transferred human T helper (Th)2 cells obtained from atopic dermatitis skin lesions or peripheral blood T cells selectively migrate to the human skin grafts of these SCID mice in response to defined chemokines locally injected in the human skin grafts. Homing of human T cells into the human skin on SCID-hu Skin mice is a specific process since it only occurs in response to chemokine ligands that are specific for the chemokine receptors expressed on the migrating T cells. This mechanistic model allows analysis of the relevant steps involved in human T-lymphocyte migration into inflamed skin. In addition, it is successfully used for preclinical testing of drug candidates that are highly selective for human target molecules associated with the different steps of T cell migration in an environment that resembles the physiologic or pathologic conditions occurring in man. Copyright 2002 Elsevier Science B.V.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12535803     DOI: 10.1016/s0022-1759(02)00422-2

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  2 in total

1.  Visualizing CD4 T-cell migration into inflamed skin and its inhibition by CCR4/CCR10 blockades using in vivo imaging model.

Authors:  X Wang; M Fujita; R Prado; A Tousson; H-C Hsu; A Schottelius; D R Kelly; P A Yang; Q Wu; J Chen; H Xu; C A Elmets; J D Mountz; C K Edwards
Journal:  Br J Dermatol       Date:  2009-10-15       Impact factor: 9.302

2.  A novel highly potent therapeutic antibody neutralizes multiple human chemokines and mimics viral immune modulation.

Authors:  Michelle L Scalley-Kim; Bruce W Hess; Ryan L Kelly; Anne-Rachel F Krostag; Kurt H Lustig; John S Marken; Pamela J Ovendale; Aaron R Posey; Pamela J Smolak; Janelle D L Taylor; C L Wood; David L Bienvenue; Peter Probst; Ruth A Salmon; Daniel S Allison; Teresa M Foy; Carol J Raport
Journal:  PLoS One       Date:  2012-08-17       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.